The clinical potential of ARGX-111, an afucosylated anti-MET antibody, in hematological malignancies and suppression of metastasis

Date 04 March 2015
Event 13th International Congress on Targeted Anticancer Therapies
Session Poster awarding ceremony
Topics Anti-Cancer Agents & Biologic Therapy
Drug Development
Haematologic Malignancies
Presenter Natalie de Jonge